Brief: Bioventus Q1 sales USD 119.1 million
16/05/2023 21:25
May 16 (Reuters) - Bioventus Q1 adjusted gross profit USD 88.3 million. * Q1 net income USD -174.4 million * Q1 adjusted operating income USD 13.5 million * Q1 adjusted EPS USD -0.26 * Q1 adjusted EBITDA USD 17 million * Q1 sales USD 119.1 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks